I personally think it should outrun NEU on success of Phase 3, then we have DMX 700 for COPD , FSGS projected here around 300,000 people in 7 -8 countries but we have to take into account for People in the other parts of the world which includes India and other countries where atleast 10-20 percent with this disease can afford the treatment
I personally think it should outrun NEU on success of Phase 3,...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.5¢ |
Change
0.040(8.79%) |
Mkt cap ! $272.0M | |||
| Open | High | Low | Value | Volume |
| 44.5¢ | 50.5¢ | 44.0¢ | $5.609M | 11.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1040 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
49.5¢ |
Change
0.040 ( 9.25 %) |
||||
| Open | High | Low | Volume | ||
| 44.5¢ | 50.0¢ | 44.5¢ | 6624928 | ||
| Last updated 15.57pm 31/05/2024 ? | |||||
| DXB (ASX) Chart |